Showing 109 results
-
Media Release /Novartis Canada applauds the positive funding recommendations for Scemblix® (asciminib) for both newly diagnosed and previously treated patients with Philadelphia chromosome-positive chronic myeloid…
-
Media Release /Novartis applauds Ontario’s bold leadership in launching the FAST program, which accelerates access to breakthrough therapies like Scemblix® for patients living with cancer.Scemblix® (asciminib) was…
-
Media Release /Quebec has the highest rate of breast cancer in Canada.1 The Government of Quebec recently endorsed lowering the breast cancer screening age for women,2,3 reflecting the province’s commitment…
-
Media Release /The Novartis Health Equity Initiative continues to support projects tackling systemic health disparities and promoting equitable access to healthcare across Canada.To date, the initiative drew over…
-
Media Release /MONTREAL, QC, November 25, 2025 – Novartis Pharmaceuticals Canada Inc. (Novartis Canada) is pleased to announce the appointment of Dimitri Gitas as Country…
